Websites Hosted in ns1.bms.com Nameserver
The Nameserver ns1.bms.com have a IP Address of 198.155.167.250 which is hosted on United States.
Bristol-Myers Squibb - A global biopharmaceutical company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bristol-Myers Squibb Canada - Home
To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bristol-Myers Squibb | Home
Bristol-Myers Squibb é hoje uma BioPharma focada na produção de medicamentos inovadores que supram as necessidades médicas. Confira isso e mais: estudos clínicos, materiais de minimização de risco e um conteúdo exclusivo para profissionais de saúde.
Bristol-Myers Squibb France
Bristol-Myers Squibb est une entreprise biopharmaceutique globale dont la mission est de découvrir, développer et mettre à disposition des médicaments innovants pour aider les patients à vaincre des maladies graves.
BMSPAF: Bristol-Myers Squibb Patient Assistance Foundation
The Bristol-Myers Squibb Patient Assistance Foundation is a non-profit organization that provides temporary assistance to qualifying patients with a financial hardship who generally have no private prescription drug insurance.
ELIQUIS® (apixaban) | Official Site | Safety Info
ELIQUIS is used to reduce the risk of stroke & blood clots in people who have AFib, not due to a heart valve problem. Read Important Safety & Prescribing Info including Boxed WARNING & Medication Guide.
ORENCIA® (abatacept) Official Site
ORENCIA® (abatacept), official website; learn about rheumatoid arthritis and how to take ORENCIA. Use live chat to answer your questions and review Important Safety Information and Prescribing Information
COUMADIN (warfarin sodium) tablets
Learn about COUMADIN and read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.
Hep C Study Connect - Home
Overview of hepatitis C and why a clinical study may be an option for some people.
SPRYCEL® (dasatinib)
SPRYCEL® (dasatinib) is a prescription medicine used to treat adults who have newly diagnosed Ph+ CML in chronic phase. The effectiveness of SPRYCEL in these patients is based on certain response rates from a 1-year study that is ongoing to look at results over a longer period of time. SPRYCEL is also approved for...